Cowen Inc’s AbbVie ABBV Stock Holding History

Cowen Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$29K	Buy	143,500 +93,500	+187%	+$7.35M	﹤0.01%	356
2019 Q1	$68K	Buy	+50,000	New	+$4.09M	0.01%	250
2017 Q2	–	Sell	-50	Closed	-$326K	–	308
2017 Q1	$326K	Buy	+50	New	+$3.14K	0.02%	190
2014 Q4	–	Sell	-25,000	Closed	-$1.44M	–	231
2014 Q3	$1.44M	Buy	+25,000	New	+$1.39M	0.15%	122

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Cowen Inc's ABBV Position: Q2 2019 in Review

Cowen Inc sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 10,750 shares — an estimated $845K sold.

Cowen Inc first reported a position in ABBV in Q3 2014 and held it in 6 quarters. The position peaked at $2.43M in Q2 2015. 2,020 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Cowen Inc reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
Cowen Inc sold 10,750 AbbVie shares in Q2 2019, an estimated $845K.
Cowen Inc first reported a position in AbbVie in Q3 2014 and held it in 6 quarters.
Cowen Inc's AbbVie position peaked at $2.43M in Q2 2015.
2,020 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.